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Abstract
Glucose metabolism is under the cooperative regulation of both insulin receptor (IR) and b2-adrenergic receptor (b2AR),
which represent the receptor tyrosine kinases (RTKs) and seven transmembrane receptors (7TMRs), respectively. Studies
demonstrating cross-talk between these two receptors and their endogenous coexpression have suggested their possible
interactions. To evaluate the effect of IR and prospective heteromerization on b2AR properties, we showed that IR
coexpression had no effect on the ligand binding properties of b2AR; however, IR reduced b2AR surface expression and
accelerated its internalization. Additionally, both receptors displayed a similar distribution pattern with a high degree of
colocalization. To test the possible direct interaction between b2AR and IR, we employed quantitative BRET
2 saturation and
competition assays. Saturation assay data suggested constitutive b2AR and IR homo- and heteromerization. Calculated
acceptor/donor (AD50) values as a measure of the relative affinity for homo- and heteromer formation differed among the
heteromers that could not be explained by a simple dimer model. In heterologous competition assays, a transient increase
in the BRET2 signal with a subsequent hyperbolical decrease was observed, suggesting higher-order heteromer formation.
To complement the BRET2 data, we employed the informational spectrum method (ISM), a virtual spectroscopy method to
investigate protein-protein interactions. Computational peptide scanning of b2AR and IR identified intracellular domains
encompassing residues at the end of the 7th TM domain and C-terminal tail of b2AR and a cytoplasmic part of the IR b chain
as prospective interaction domains. ISM further suggested a high probability of heteromer formation and homodimers as
basic units engaged in heteromerization. In summary, our data suggest direct interaction and higher-order b2AR:IR oligomer
formation, likely comprising heteromers of homodimers.
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Introduction
The functional interplay between different classes of receptors
represents a means of fine-tuning the control of cellular functions
that could be fundamental for understanding pathologic condi-
tions and responses to therapeutic agents that interact with cell-
surface receptors. Originally, 7 transmembrane receptors
(7TMRs) and receptor tyrosine kinases (RTKs), together with
their respective downstream effectors, were thought to represent
distinct and linear signaling units; however, recent studies have
provided evidence for functional crosstalk between these different
types of receptors [1].
Glucose metabolism is under the cooperative regulation of the
RTK insulin receptor (IR) and b2-adrenergic receptor (b2AR), a
representative 7TMR. The anabolic action of insulin promotes
glycogen synthesis, glucose uptake in skeletal muscle and lipid
storage. By contrast, catecholamines act in opposition to insulin,
stimulating glycogen breakdown, gluconeogenesis, and lipolysis
[2]. They play an important role in counter-regulation of insulin-
induced hypoglycemia. The ability of insulin to counter regulate
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catecholamine action at the tissue/cellular level is crucial for the
‘‘tight’’ regulation of serum glucose levels, and interaction between
IR and b2AR could be a required action in this process.
At the molecular level, the ability of insulin to counter regulate
b2ARs can be exerted through insulin-stimulated phosphorylation
of b2AR and its subsequent internalization. An early in vitro study
demonstrated that, in the presence of insulin, IR catalyzes the
phosphorylation of b2AR predominantly at residues located in the
cytoplasmic tail of b2AR–i.e., Tyr350/Tyr354, and Tyr364 [3]–a
finding that was consistent with the hypothesis that IR directly
interacts with and phosphorylates b2AR. Phosphorylated b2AR
Tyr350 creates a phosphotyrosine Src homology 2 (SH2) binding
domain, which effectively precludes b2AR from coupling to its
cognate G-protein (GaS) and enables binding of the adaptor Grb2,
the p85 regulatory subunit of phosphoinositide 3-kinase (PI3K) or
the GTPase dynamin; all of the latter molecules are involved in
7TMR trafficking [4,5,6]. In addition, insulin-induced activation
of MAPKs, ERK 1 and ERK 2, is potentiated by b2AR via a
mechanism that requires the integrity of Tyr350 [4]. Thus, the
functional cross-talk between b2AR and IR may be to fine tune the
signals from multiple receptor signaling pathways. Recently, Fu
et al. [7] described an IR:b2AR complex in the mouse heart,
indicating that cross-talk between these two receptors could
provide a molecular basis for the pathophysiology of metabolic
and cardiovascular dysfunction under insulin-resistant states.
b2AR and IR are also endogenously coexpressed in other cell
types–i.e., pancreatic beta cells, adipocytes, liver cells, skeletal
muscle cells and astrocytes [8,9,10]. Therefore, the formation of
heteromeric complexes consisting of these two receptors may be
plausible.
In the past decade, the concept that 7TMRs can exist as dimers
or higher-order oligomers has advanced rapidly [11,12], and
biophysical techniques based on resonance energy transfer (RET)
such as BRET have become methods of choice in receptor
oligomerization studies (recently reviewed in [13,14,15,16,17,18]).
Utilizing BRET, b2AR homo- and heteromerization with different
7TMR family members have been reported
[19,20,21,22,23,24,25].
In contrast to 7TMR-based BRET studies, BRET has been less
exhaustively employed for RTK-based studies, and an overview of
BRET studies associated with RTKs was recently reviewed by
Issad et al. [26] and Siddiqui et al. [27]. RTKs often employ
dimerization as a key factor in their activation; in fact, members of
the IR subfamily are pre-dimerized by disulfide bonds (reviewed
by De Meyts [28]). In IR studies, BRET was used to monitor the
activation state of IR [29,30,31] and its interactions with different
intracellular binding partners, including protein tyrosine phos-
phatase-1B [32], Grb14 [33] and IRS1, IRS4 and Shc [34]. IR
can also form hybrid heterotetramers with the insulin-like growth
factor-1 (IGF-1) receptor, exemplifying that IR can comprise
heteromers that are products of independent genes [35].
In addition to interfamily receptor heteromerization–i.e.,
7TMR:7TMR and RTK:RTK pairs–a physiologically relevant,
direct physical interaction between the 7TMR adenosine A2A
receptor (A2A-AR) and RTK fibroblast growth factor receptor
(FGFR) was demonstrated [36]. Evidence for other 7TMR:RTK
complexes was also provided [37,38,39]. Computer-assisted
analysis suggested that the N- and C-termini, as well as the third
intracellular loop (ICL3) of 7TMRs show a propensity toward
unstructured conformation, and could potentially interact with
domains of other receptors/receptor-interacting proteins (re-
viewed in [40]).
To test whether b2AR and IR are prospective interaction
partners, we employed the following methods: i) radioligand
binding and enzyme-linked immunosorbent assay (ELISA) to
determine the receptor-binding properties and surface expression,
as well as to quantify receptor internalization processes; ii) confocal
microscopy to detect possible colocalization between b2AR and
IR; iii) BRET2 proximity assays consistent with the direct
interaction between b2AR and IR; and iv) the informational
spectrum method (ISM), a virtual spectroscopy method to
investigate protein-protein interactions [41,42], to identify impor-
tant informational characteristics of the interaction between b2AR
and IR and to predict domains potentially involved in their
interaction. Prior studies have proved this bioinformatics approach
to be effective in identifying protein–protein interaction partners
and some of them were also confirmed experimentally [43,44].
Materials and Methods
Materials
Molecular biology reagents, as well as the tissue culture media
and reagents, were purchased from Sigma-Aldrich (St. Louis, MO,
USA) and Gibco Invitrogen Corporation (Breda, the Netherlands),
unless otherwise specified. [125I]-Iodopindolol was obtained from
PerkinElmer (Boston, MA, USA). The ligands pindolol and
isoproterenol were purchased from Sigma-Aldrich, and recombi-
nant human insulin S100 was from Novo Nordisk A/S (Bagsværd,
Denmark). Coelenterazine 400a was purchased from Biotrend
Chemikalien GmbH (Ko¨ln, Germany). Anti-hemagglutinin (HA)
high-affinity rat monoclonal antibodies were from Roche (Basel,
Switzerland). Anti-rat horseradish peroxidase (HRP)-conjugated
antibodies and anti-rat TRITC-conjugated antibodies were from
Sigma-Aldrich.
Receptor fusion constructs
Human HA-tagged b2AR (HA-b2AR) cDNA in the vector
pcDNA3.1 was purchased from Missouri S&T cDNA Resource
Center (University of Missouri-Rolla, USA). HA-b2AR C-termi-
nally tagged with Renilla luciferase 8 (RLuc8) (b2AR-RLuc8) was
made using standard molecular biology techniques and was
verified by sequencing. WT human IR isoform A that lacks exon
11 and IR C-terminally tagged with the green fluorescent protein
variant 2 (IR-GFP2) were generated and verified at Novo Nordisk
A/S. C-terminally RLuc8-tagged IR (IR-RLuc8), C-terminally
GFP2-tagged b2AR (b2AR-GFP
2) and the membrane-inserted
GFP2-tagged construct (GFP2-17aa) were the same as described
previously [24,34,45]. All of the generated cDNA clones were
inserted into the expression vector pcDNA3.1(+).
Cell culture and transfection
HEK-293 cells (European Collection of Animal Cell Cultures,
Salisbury, UK) were routinely maintained and passaged in
Dulbecco’s modified Eagle’s Medium (DMEM) supplemented
with 10% (v/v) heat-inactivated fetal calf serum, 2 mM Glutamax-
I, penicillin (100 U/mL) and streptomycin (100 mg/mL) at 37uC
in a humidified atmosphere of 5% (v/v) CO2. For transient
transfection, HEK-293 cells were seeded at a density of ,16106
cells per 60-mm tissue culture dish or at a density of 46106 cells
per 75-cm2 flask and transfections were performed the following
day using Lipofectamine 2000 according to the manufacturer’s
instructions. Cells were harvested 48 h after transfection, the cell
number was determined using a cover-slipped hemocytometer,
and the cells were resuspended in Dulbecco’s PBS supplemented
with Ca2+/Mg2+, 1 g/L glucose and 36 mg/L sodium pyruvate to
a density of 16106 cells/mL, unless otherwise stated.
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Luminescence and fluorescence measurements
The expression levels of RLuc8- and GFP2-tagged receptor
constructs were monitored by total luminescence and fluorescence
measurements as previously described [46]. For luminescence
measurements, ,26105 of resuspended cells were distributed in
96-well microplates (white Optiplate; Packard BioScience, Mer-
iden, CT, USA). After the addition of coelenterazine 400a to a
final concentration of 5 mM, total luminescence was measured
using a TriStar LB 942 microplate reader (Berthold Technologies,
Bad Wildbad, Germany). For fluorescence measurements,
,26105 of resuspended cells from the same transfections were
plated in black 96-well FIA plates (Greiner Bio-One, Frickenhau-
sen, Germany). Total fluorescence was measured using the TriStar
LB 942 microplate reader with an excitation filter at 380 nm and
an emission filter at 515 nm. Background values obtained with
mock-transfected HEK-293 cells were subtracted in both mea-
surements, and the mean values of triplicate wells/sample were
then calculated.
Receptor Binding Assay
To establish a relationship between the luminescence/fluores-
cence signals generated by RLuc8 and GFP2-tagged b2ARs and
cell-surface receptor number, radioligand binding assays were
carried out on whole cells as previously described [47]. After
transfections with increasing amounts of cDNA (0.01 to 2 mg) for
either b2AR-RLuc8 or b2AR-GFP
2, cells were plated onto 24-well
plates at a density of ,16105 cells per well. An aliquot of cells
(,56105) from each transfection was also transferred into a 60-
mm dish for total luminescence/fluorescence measurements as
described above. For the whole-cell radioligand binding assay,
cells were washed once with assay buffer (HEPES-modified
DMEM with 0.1% bovine serum albumin (BSA)) before being
incubated with the b2AR antagonist [
125I]-iodopindolol
(30,000 cpm/well) and increasing concentrations of unlabeled
pindolol (10–12 to 1025 M final concentration) in assay buffer for
2 h at 4uC. Cells were then washed 3 times with ice-cold PBS and
solubilized with 0.2 M NaOH and 1% sodium dodecyl sulfate
(SDS) solution, and then the radioactivity levels were determined
using a c counter (LKB Wallac, Turku, Finland). Determination of
the radioactivity levels was performed in triplicate. Binding
parameters were determined from displacement curves generated
by a sigmoidal dose-response curve fit (GraphPad Prism 5.0).
Receptor density (Bmax), expressed as the receptor number per cell,
was calculated as previously described by Ramsay et al. [48].
Whole-cell radioligand binding assays were also performed with
cells expressing b2AR alone or in combination with IR.
Displacement curves were generated using [125I]-iodopindolol
(30,000 cpm/well) and increasing concentrations of isoproterenol
or isoproterenol and insulin, and IC50 values were then
determined using GraphPad Prism 5.0.
ELISA
ELISA assays for the measurement of surface-expressed HA-
b2AR and quantification of receptor internalization were per-
formed as described previously [49]. Briefly, HEK-293 cells were
transiently transfected with either b2AR-RLuc8 alone or b2AR-
RLuc8 and IR-GFP2. One microgram of each receptor was used,
and the total amount of cDNA used for transfection was kept
uniform by adding empty pcDNA3.1 vector. After transfection,
cells were seeded at a density of ,16105 cells per well in a 24-well
plate. An aliquot of cells (,56105) from each transfection was also
transferred into a 60-mm dish for total luminescence/fluorescence
Table 1. Pharmacological properties of b2AR fusion constructs expressed in HEK-293 cells.
Receptor IC50 (nM)
HA-b2AR 1.5860.26
HA-b2AR-RLuc8 1.1660.11
b2AR-GFP
2 1.8860.58
b2AR-RLuc 0.9460.06
a
aData from Vrecl et al. [47].
HEK-293 cells expressing HA-b2AR, b2AR-GFP
2 or HA-b2AR-RLuc8 were incubated with [
125I]-iodopindolol and increasing concentrations of pindolol (10–12 to 10–5 M
final concentration). IC50 values were generated using a sigmoidal dose-response curve fit (GraphPad Prism 5.0). Data are expressed as the means 6 S.E. of three
independent experiments performed in triplicate.
doi:10.1371/journal.pone.0112664.t001
Table 2. Effect of IR coexpression on the pharmacological properties of b2AR in HEK-293 cells.
IC50 (nM)
Ligands HA-b2AR HA-b2AR+IR
pindolol 1.5860.26 1.1560.15
isoproterenol 576.76134.2 406.5636.5
insulin ND ND
pindolol+insulin 2.7360.58 1.1360.23
ND – not detected.
HEK-293 cells expressing HA-b2AR alone or HA-b2AR together with IR at a 1:1 cDNA ratio were incubated with [
125I]-iodopindolol and increasing concentrations of the
indicated ligands (10–12 to 10–5 M final concentration). When the concomitant effect of pindolol and insulin was tested, insulin was added to a 0.1 mM final
concentration. IC50 values were generated using a sigmoidal dose-response curve fit (GraphPad Prism 5.0). Data are expressed as the means6 S.E. of three independent
experiments performed in triplicate.
doi:10.1371/journal.pone.0112664.t002
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measurements as described above. After 48 h, cells were first
subjected to a 2-h starvation period, and then were treated as
required in HEPES-modified DMEM with 0.1% BSA for 30 min
at 37uC before fixing with 4% paraformaldehyde for 20 min at
4uC. Cells were then washed 3 times in PBS and blocked (PBS
containing 1% BSA) for 60 min at room temperature. Cells were
kept at room temperature for all of the subsequent steps. First, cells
were incubated for 2 h with anti-HA antibody at a 1:600 dilution.
After 3 washes, cells were incubated with anti-rat horseradish
peroxidase-conjugated antibody at a 1:1000 dilution. After
extensive washing, the reaction was developed using the 3, 39, 5,
59-tetra-methylbenzidine (TMB) liquid substrate system. The
enzymatic reaction was stopped after 30 min at 37uC by adding
0.2 N sulfuric acid. The absorbances were measured at 450 nm
using the microplate reader Rosys Anthos 2010 (Anthos Labtec
Instruments, Wals, Austria). Determinations were made in
triplicate.
Receptor internalization assay
The b2AR internalization assay was performed as described
previously [47]. Briefly, HEK-293 cells were transiently transfect-
ed with either b2AR alone or b2AR and IR. One microgram of
each receptor was used, and the total amount of cDNA used for
transfection was kept uniform by adding empty pcDNA3.1 vector.
After 2 days, cells were first subjected to a 2-h starvation period in
assay medium (HEPES-modified DMEM with 0.01% BSA) before
being incubated with 10 mM isoproterenol or a combination of
10 mM isoproterenol and 0.1 mM insulin S100 in assay medium
for time intervals ranging from 5 min to 60 min at 37uC. Cells
were then placed on ice, washed 3 times with ice-cold PBS and
incubated for 2 h with [125I]-iodopindolol in the presence or
absence of 10 mM pindolol at 4uC. Specific binding in each
fraction was determined as the difference between radiolabeled
ligand detected in the presence and absence of 10 mM pindolol.
Receptor sequestration was then defined as the decrease in specific
[125I]-iodopindolol binding compared with the total binding
obtained in untreated cells. The amount of internalized receptors
as a function of time was fitted using a one-site binding (hyperbola)
curve fit (GraphPad Prism 5.0) to estimate the half-time of
internalization (t1/2). All of the time points were performed in
triplicate.
Confocal microscopy
HEK-293 cells were transiently transfected with constructs
encoding HA-tagged and/or GFP2-tagged receptor constructs,
trypsinized, and plated on poly-L-lysine-coated glass coverslips in
complete DMEM. After 48 h, cells were treated as required with
either 10 mM isoproterenol, 0.1 mM insulin S100 or the combi-
nation of both in HEPES-modified DMEM for 10 min at 37uC.
Upon treatment, cells were washed with ice-cold PBS and fixed
with 4% paraformaldehyde for 20 min at 4uC. Following washing
(3 times in PBS), cells were permeabilized with PBS containing
0.01% Triton X-100 for 20 min. To reduce the nonspecific
binding, cells transfected with the HA-tagged receptors were
incubated in blocking solution (PBS containing 1% BSA) for
30 min. Subsequently, cells were incubated with a 1:100 dilution
of primary rat anti-HA antibodies in PBS overnight at 4uC.
Following washing (3 times in PBS), cells were incubated with a
1:50 dilution of secondary rabbit anti-rat TRITC-conjugated
antibodies for 60 min at room temperature in the dark. Cells were
Figure 1. Effect of IR coexpression on b2AR surface expression and
internalization in HEK-293 cells. (A) ELISA was performed on intact HEK-
293 cells transiently transfected with HA-b2AR-RLuc8 alone (open bars)
or HA-b2AR-RLuc8 together with IR-GFP
2 (hatched bars) at a 1:1 cDNA
ratio using an antibody directed against the HA epitope. Antibody
binding, as an index of receptor surface expression, was determined by
measuring the absorbance at 450 nm. HA-b2AR-RLuc8 and IR-GFP
2 total
relative expression was determined by luminescence and fluorescence
measurement, respectively. Total luminescence was measured after the
addition of the RLuc substrate coelenterazine 400a. Total fluorescence
was measured with an excitation filter at 380 nm and an emission filter
at 515 nm. Fold change is relative to open bars for surface expression
and total luminescence, and relative to hatched bars for total
fluorescence. Data are expressed as the means 6 S.E. of three
independent experiments performed in triplicate. *, p,0.05 as
compared with HA-b2AR-RLuc8 transfected cells. (B, C) Effect of IR
coexpression on the time-course of b2AR internalization. HEK-293 cells
were transiently transfected with either b2AR (dotted line) or b2AR
together with the IR (solid line) at a 1:1 cDNA ratio. b2AR internalization
was first induced by (B) isoproterenol (10 mM) or (C) the combination of
isoproterenol (10 mM) and insulin (0.1 mM) for the indicated time
intervals. Receptor sequestration was then defined as the decrease in
specific [125I]-iodopindolol binding compared with the total binding
obtained in untreated cells. The amount of internalized receptors as a
function of time was fitted using a one-site binding (hyperbola) curve fit
(GraphPad Prism 5.0). Data are expressed as the means 6 S.E. from
three independent experiments performed in triplicate.
doi:10.1371/journal.pone.0112664.g001
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then mounted using an anti-fading ProLong Gold reagent
(Molecular Probes, the Netherlands), sealed and examined under
an oil immersion objective (Planapo 406, N.A. = 1.25) using a
Leica multispectral confocal laser microscope (Leica TCS NT,
Heidelberg, Germany). The sequential detection of GFP2- and
TRITC-stained receptors was achieved using excitation laser lines
at 488 nm (argon) and 543 nm (helium-neon), respectively. The
fluorescence from the channels was collected sequentially, and
images were produced using an 8-fold frame averaging a
resolution of 102461024 pixels. Optical sections (1.0 mm) were
acquired, and representative sections corresponding to the middle
of the cells were presented using Adobe Photoshop 7.0 computer
software.
BRET2 saturation and competition assays
To derive BRET2 saturation curves, HEK-293 cells were
transiently cotransfected with constant amounts of the constructs
encoding RLuc8-tagged receptors together with increasing
amounts of the constructs encoding GFP2-tagged receptors. For
BRET2 competition assays, HEK-293 cells were cotransfected
with constant amounts of RLuc8- and GFP2-tagged receptor
constructs and with increasing amounts of untagged receptors.
BRET2 assays were performed as described previously [24,46,47].
Briefly, 180 ml of resuspended cells containing ,26105 cells was
distributed in 96-well microplates (white Optiplate; Packard
BioScience, Meriden, CT, USA). After the addition of coelenter-
azine 400a to a final concentration of 5 mM using an injector,
readings were collected (TriStar LB 942 microplate reader,
Berthold Technologies, Bad Wildbad, Germany). Signals at
410 nm (RLuc8 luminescence signal) and 515 nm (emission of
light from excited GFP2) were measured sequentially, and 515/
410 ratios (BRET2 signal) were calculated. The results were
expressed in milliBRET units (mBU); BRET ratio 6 1000. The
expression levels of RLuc8- and GFP2-tagged constructs for each
experiment were assessed by total luminescence and fluorescence
measurements as described above. Determinations were made in
triplicates.
Figure 2. Visualization of b2AR and IR cellular localization by confocal microscopy. IR-GFP
2 and HA-b2AR-RLuc8 cellular localization is
shown in untreated (control) cells (upper panels) and cells concomitantly treated with isoproterenol (10 mM) and insulin (0.1 mM) for 10 min at 37uC
(lower panels). The green color indicates IR-GFP2; red indicates HA-b2AR-RLuc8; yellow/orange is the overlapping region indicating colocalization of
IR-GFP2 and HA-b2AR-RLuc8. Note that both receptors have comparable localization in untreated and agonist-stimulated cells and that they exhibit a
high degree of colocalization. However, in agonist-stimulated cells a proportion of intracellular receptors did not colocalize. Objective 406and zoom
factor 4 apply for all images.
doi:10.1371/journal.pone.0112664.g002
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BRET2 assay data evaluation
The BRET2 values were fitted using the following equation for
dimers: BRET=BRETmax(1/(1+AD50/X)), where X is the ratio
of acceptor (A; Receptor-GFP2) to donor ((D; Receptor-RLuc8)
molecules. BRETmax is the maximum BRET
2 signal when all of
the donor molecules are interacting with acceptor molecules. AD50
value corresponds to the acceptor/donor ratio providing 50% of
the BRETmax and reflects the relative affinity of the acceptor
(GFP2-tagged receptor) for the donor molecules (RLuc8-tagged
receptor). Fitting parameters were compared using Welch’s t-test.
Simplistic BRET model for trimers with different
association affinities
The BRET model for trimers is based on the Veacht and Steyer
(1977) concept [50]. The theoretical saturation curve for trimers
with the same association affinity is:
BRET~
Iacceptor
Idonor
~
2EAADz2EADD
1{2Eð ÞAADz2 1{Eð ÞADDzDDD ð1Þ
where A, D and E are acceptor, donor and energy transfer
efficiency, respectively. If we have different affinities for the
formation of AAD trimer we introduce enhancement factor X:
BRET~
Iacceptor
Idonor
~
2EXAADz2EADD
1{2Eð ÞXAADz2 1{Eð ÞADDzDDD
ð2Þ
BRET competition assay simulation for trimers with different
energy transfer ratio
The BRET model for trimer competition is based on the Veacht
and Steyer (1977) concept [50]. For receptors with equal affinities
to form trimers we determine the frequency of each trimer type
(A= acceptor, D=donor and W=wild type receptor):
A D Wð Þ3~AAAz3AADz3AAWz3ADD
z6ADWz3AWWz3DDWz3DWWzDDDzWWW
ð3Þ
BRET is defined as a ratio of light emission from acceptor
divided by that of the donor. E is resonance energy transfer ratio:
BRET~
Iacceptor
Idonor
~
2EAADz2EADDz2EADW
1{2Eð ÞAADz2 1{Eð ÞADDz2 1{Eð ÞADWz2DDWzDWWzDDD
ð4Þ
If the energy transfer ratio E is different for ADW trimers the
following equation is obtained:
Figure 3. BRET2 saturation curves of b2AR and IR homo- and heteromers. HEK-293 cells were transiently cotransfected with a constant
amount of RLuc8-tagged and increasing amounts of GFP2-tagged receptor encoding constructs. BRET2 values were plotted as a function of the ratio
between the acceptor and donor fusion proteins (A/D ratio). A dataset is composed of 3–5 independent saturation experiments that were fitted using
a nonlinear regression equation assuming a single binding site using GraphPad Prism 5.0 (Fitting results are found in Table 3).
doi:10.1371/journal.pone.0112664.g003
ð4Þ
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BRET~
Iacceptor
Idonor
~
2E1AADz2E1ADDz2E2ADW
1{2E1ð ÞAADz2 1{E1ð ÞADDz2 1{E2ð ÞADWz2DDWzDWWzDDD
ð5Þ
Informational spectrum method (ISM)
The ISM is based on a model that assigns to each amino acid a
defined parameter describing a physico-chemical property in-
volved in the biological activity of the protein and corresponding
to electron-ion interaction potential (EIIP). These values deter-
mine the electronic properties of the amino acids responsible for
their intermolecular interactions [51].
The obtained numerical sequence, representing the primary
structure of a protein, is then subjected to a discrete Fourier
transformation defined as follows:
X nð Þ~
X
x mð Þe{j 2=Nð Þnm, n~1,2,:::,N=2 ð6Þ
where x(m) is the m-th member of a given numerical series, N is
the total number of points in this series, and X(n) are discrete
Fourier transformation coefficients. These coefficients describe the
amplitude, phase and frequency of sinusoids, which comprised the
original signal. The absolute value of the complex discrete Fourier
transformation defines the amplitude spectrum and phase
spectrum. The complete information concerning the original
sequence is contained in both spectral functions. However, in the
case of protein analysis, relevant information is presented in an
energy density spectrum (for a review, see [51]) defined as follows:
S nð Þ~X nð ÞX  nð Þ~1=2X nð Þ1=22, n~1,2,:::,N=2: ð7Þ
Thus, the initial information defined by the sequence of amino
acids is now presented in the form of the informational spectrum
(IS), representing the series of frequencies and their amplitudes.
The IS frequencies correspond to the distribution of structural
motifs with defined physico-chemical characteristics responsible
for the biological function of a protein. When comparing proteins
that share the same biological or biochemical function, ISM allows
the detection of code/frequency pairs that are specific for their
common biological properties or correlate with their specific
interaction. This common informational characteristic of sequenc-
es is determined by a cross-spectrum (CS) for two proteins or
consensus informational spectrum (CIS) for two or more proteins–
i.e., the Fourier transformation of the correlation function for the
spectrum. In this way, any spectral component (frequency) not
present in all of the compared ISs is eliminated. Peak frequencies
in CIS are common frequency components for the analyzed
sequences. A measure of similarity for each peak is the signal-to-
noise ratio (S/N), representing the ratio between the signal
intensity at one particular IS frequency and the main value of the
whole spectrum. If a CIS is calculated for a group of proteins with
different primary structures, and strictly defined peak frequencies
are found, the analyzed proteins likely participate in a mutual
interaction or have a common biological function. The ISM was,
thus far, successfully applied in the structure-function analysis of
different protein sequences [51], prediction of new protein
interactors [43] and identification of protein domains responsible
for long-range interactions [52,53].
Computational peptide scanning
Computational peptide scanning was used to define linear
protein regions that contribute the most to the amplitude and
signal to noise ratio at the characteristic frequency and, therefore,
are responsible for the interaction(s) described by the particular
spectral characteristic. To identify the regions with the highest
amplitudes at predefined Fourier frequencies, the entire sequences
of b2AR and IR were scanned by the ISM algorithm with
overlapping windows of different lengths, leading to the identifi-
cation of regions with the highest amplitudes at predefined Fourier
frequencies.
Datasets
The sequences used for bioinformatics analysis were retrieved
from the Uniprot database with the following accession numbers:
P07550 (human b2AR) and P06213 (human IR isoform A that
lacks exon 11).
Statistical analysis
Statistical significance was determined using Student’s t-test and
Welch’s t-test. Differences were considered statistically significant
at a p value less than 0.05.
Ethics Statement
N/A.
Results
Characteristics of the b2AR fusion constructs
Pharmacological characterization of the human HA-tagged
b2AR (HA-b2AR) fused at the C-terminus with either the energy
donor RLuc8 or energy acceptor GFP2 was performed using
Table 3. BRET2 saturation assay fitting results.
Receptor pair BRETmax (mBU) AD50
b2AR-RLuc8:b2AR-GFP
2 437635 1.760.5
IR-RLuc8:IR-GFP2 143610 1.360.4
b2AR-RLuc8:IR-GFP
2 7864 0.560.1
IR-RLuc8:b2AR-GFP
2 131611 2.960.7
BRET2 data from saturation assays were fitted using the following equation for dimers: BRET = BRETmax(1/(1+AD50/X)) where X is the ratio of acceptor (A; Receptor-GFP2)
to donor (D; Receptor-RLuc8) molecules. The BRETmax is the maximal BRET obtained for a given pair and AD50 value corresponds to the A/D ratio providing 50% of the
BRETmax. The best-fit parameters and standard errors were derived from the data presented in Fig. 3. Fitting parameters were compared using Welch’s t-test. Statistical
analysis shows that AD50 and BRETmax values differ significantly (p#0.05) between all of the tests.
doi:10.1371/journal.pone.0112664.t003
ð5Þ
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radioligand binding assays (Table 1). The IC50 values of pindolol
for HA-b2AR-RLuc8 and b2AR-GFP
2 were in agreement with
those obtained for HA-b2AR and were also in the range previously
reported for b2AR-RLuc fusion construct [47]. IR fusion
constructs were previously characterized [34]. Radioligand bind-
ing assays were also performed with HEK-293 cells cotransfected
Figure 4. Homologous and heterologous BRET2 competition assay. (A, B) HEK-293 cells were cotransfected with a constant amount of
RLuc8- and GFP2-tagged receptor while increasing the amount of untagged receptor. In the homologous competition assay (dotted line), BRET2
signals decreased with an increasing amount of WT receptor confirming the competition effect. In the heterologous BRET2 assay (solid line), where
different WT receptors were used to compete with the tagged homomer receptor pair, a transient increase in the BRET2 signal with a subsequent
hyperbolical decrease was observed. BRET0 is the BRET
2 signal obtained in the absence of competitor. Data are expressed as the means 6 S.E. from
three independent experiments performed in triplicate. (C, D) Receptor-GFP2/Receptor-RLuc8 expression ratio (GFP2/RLuc8 ratio) in each sample was
evaluated for total luminescence and total fluorescence. Total luminescence and total fluorescence was measured as described under Material and
Methods. Note that GFP2/RLuc8 ratio was roughly constant in the absence or presence of increasing concentrations of competitor (untagged b2AR or
IR). Data are expressed as the means 6 S.E. from three independent experiments performed in triplicate.
doi:10.1371/journal.pone.0112664.g004
Figure 5. Informational spectrum (IS) of (A) b2AR, (B) IR and (C) cross-spectrum (CS) of b2AR and IR. CS of b2AR and IR revealed common
information corresponding to the IS frequency F(0.216) (panel C).
doi:10.1371/journal.pone.0112664.g005
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with the HA-b2AR and IR at a 1:1 cDNA ratio. The obtained
IC50 values for the tested b2AR ligands–i.e., pindolol and
isoproterenol–were comparable in b2AR- and in b2AR- and IR-
expressing cells. Similarly, heteromerization with b3AR did not
affect the binding properties of b2AR [20]. Insulin neither
competed for binding against [125I]-iodopindolol nor affected the
IC50 values of pindolol (Table 2).
b2AR surface expression and the internalization effect of
IR coexpression
The effect of IR coexpression on b2AR surface expression and
internalization properties was evaluated by ELISA in intact cells
and by radioligand binding assays. As shown in Fig. 1A, a
significant approximately 35% decrease in b2AR surface expres-
sion was observed in HEK-293 cells cotransfected with IR
compared with b2AR-expressing cells (p,0.05). However, total
b2AR expression was not affected by IR coexpression as shown by
luminescence measurements, whereas IR expression was validated
by fluorescence measurements. Analogous observations in b2AR
surface expression were detected using radioligand binding assays,
where b2AR surface expression decreased by around 30%
(27.8962.11) in HEK-293 cells cotransfected with IR compared
with b2AR-expressing cells (p,0.05).
Additionally, ELISA measurements suggested that IR coex-
pression moderately increased isoproterenol-induced b2AR inter-
nalization, whereas concomitant treatment with isoproterenol and
insulin evoked a comparable internalization rate. Treatment with
insulin did not induce marked b2AR internalization (Figure S1).
To further examine the internalization kinetics of b2AR, HEK-
293 cells expressing either b2AR or b2AR and IR were treated
with either isoproterenol (10 mM) or a combination of both
isoproterenol (10 mM) and insulin (0.1 mM) for varying periods of
Figure 6. Mapping of the domains with maximal contribution to the frequency component F(0.216) in the informational spectrum
of (A) b2AR and (B) IR. Peptide scanning of the b2AR and IR identified regions encompassing residues at the end of the 7
th TM domain and C-
terminal tail of b2AR and a cytoplasmic part of the IR b chain as prospective interaction domains. The regions encompassing residues 325–364 in b2AR
(A) and 1269–1314 IR (B) are essential for the information represented by the frequency F(0.216). The position of the first amino acid (aa) in the
domain is shown. Panel B; the amino acid position denote the positions in IR b subunit starting from amino acid 763.
doi:10.1371/journal.pone.0112664.g006
Figure 7. Consensus informational spectrum (CIS) of b2AR:IR tetramers with the characteristic peak at F(0.216). (A) b2AR:b2AR:b2AR:IR,
(B) b2AR:b2AR:IR:IR and (C) b2AR:IR:IR:IR tetramers. Note that the interaction affinities among the receptors decreased in the order b2AR:b2AR:b2AR:IR$
b2AR:b2AR:IR:IR.b2AR:IR:IR:IR.
doi:10.1371/journal.pone.0112664.g007
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time (5 min to 1 h), and the number of cell surface binding sites
were determined (Fig. 1B and C). We found that isoproterenol-
induced steady-state proportion of internalized receptors was
approximately 38% and 44% in b2AR- and in b2AR- and IR-
expressing cells, respectively. The rate of isoproterenol-induced
b2AR internalization was significantly increased by coexpression
of IR (p,0.05), as the estimated t1/2 was 8.661.3 and
5.460.6 min in b2AR- and in b2AR- and IR-expressing cells.
Comparable results were obtained when either b2AR- or b2AR-
and IR-expressing cells were concomitantly treated with isopro-
terenol and insulin (see Fig. 1B and C). In addition, confocal
fluorescence microscopy demonstrated predominant plasma
membrane localization of the HA-b2AR-RLuc8 and IR-GFP
2
and their colocalization in untreated cells (Fig. 2, upper panels;
untreated cells). Concomitant treatment of b2AR- and IR-
expressing cells with isoproterenol and insulin (Fig. 2, lower
panels) promoted receptor redistribution to the cytoplasm,
indicating receptor internalization. Again, agonist-redistributed
b2AR and IR showed a similar distribution pattern; however, a
proportion of intracellular receptors did not colocalize.
Interaction between the b2AR and IR–BRET evidence
Considering the observed effects of IR coexpression on b2AR
surface expression and internalization, as well as colocalization of
both receptors in HEK-293 cells, we next investigated whether
proximity indicative of direct interaction occurs between b2AR
and IR by performing BRET dilution, saturation and competition
assays. To obtain an absolute value of donor [D] and acceptor [A]
molecules–i.e., Receptor-RLuc8 and Receptor-GFP2–we first
generated correlation curves between total luminescence and
fluorescence versus the number of receptor-binding sites deter-
mined by radioligand binding. The linear correlation was obtained
between the number of HA-b2AR-RLuc8 and b2AR-GFP
2
binding sites and the total luminescence and total fluorescence,
respectively (Figure S2).
The derived correlation factors to convert total luminescence
and total fluorescence into receptor number were 0.00031 and
0.0089, respectively. Thereafter, BRET2 dilution assays with a
constant [A]/[D] ratio were performed to set the concentration
range for the saturation assays and distinguish monomers from
dimers as previously described [54]. Due to the increasing noise in
calculated BRET at low luminescence intensities, the lowest
amount of HA-b2AR-RLuc8 and IR-RLuc8 cDNA used for
transfection in saturation assays was determined at 0.05 and
0.015 mg, respectively.
BRET2 saturation assays were performed to investigate homo-
and hetero-merization of b2AR and IR. The BRET
2 signal was
measured in live HEK-293 cells that were transiently transfected
with constant amounts of RLuc8-tagged (HA-b2AR-RLuc8, IR-
RLuc8) and with increasing amounts of GFP2-tagged (b2AR-
GFP2, IR-GFP2) receptor encoding constructs. In dimers and
higher oligomers, the probability of BRET interaction increases
with increasing acceptor/donor ratio until all of the acceptors have
pairs, and the maximum BRET2 level (BRETmax) or plateau is
reached. The AD50 value (also designated as BRET50; see
methods) was also included to compare the affinity for homo2/
heteromer formation. BRET2 saturation experiments data are
shown in Fig. 3 and the expression levels of RLuc8- and GFP2-
tagged receptor constructs are shown in Figure S3. For all of the
receptor combinations, the BRET2 signal was plotted as a function
of the A/D ratio increased as a hyperbolic function reaching a
saturation level (Fig. 3). Control experiments for the specificity of
the interaction were performed by cotransfecting RLuc8-tagged
receptors with increasing amounts of membrane-inserted GFP2-
tagged construct (GFP2-17aa). Plasma membrane localization of
the GFP2-17aa construct was previously demonstrated [45]. The
BRET2 signal increased linearly with the increase in fluorescence/
luminescence (GFP2/RLuc8) ratio, most likely reflecting random
collisions between the RLuc8-tagged receptors and control
unrelated GFP2-tagged construct (GFP2-17aa) (Figure S4). Satu-
ration assay data were fitted using a dimer model in the
approximation of small energy transfer [54] (Table 3). We
observed the highest BRETmax–i.e., 437 mBU in the b2AR
homologous saturation assay and considerably lower BRETmax
values for other receptor combinations. It should be stressed that
the BRETmax value depends on the distance between BRET pairs
and is not a measure of the strength of interaction between the
acceptor- and donor-tagged receptors. In homologous saturation
Table 4. The affinity of interaction between the b2AR and IR homo- and heteromers characterized by the signal-to-noise ratio (S/
N) at the characteristic frequency (F) in the consensus informational spectrum (CIS).
Dimer S/N ratio
b2AR:b2AR 24.082
b2AR:IR 15.951
IR:IR 22.407
Trimer
b2AR:b2AR:b2AR 52.867
b2AR: b22AR:IR 43.476
b2AR:IR:IR 25.605
IR:IR:IR 51.146
Tetramer
b2AR:b2AR:b2AR:b2AR 81.703
b2AR:b2AR:b2AR:IR 76.505
b2AR:b2AR:IR:IR 71.105
b2AR:IR:IR:IR 29.468
IR:IR:IR:IR 89.617
doi:10.1371/journal.pone.0112664.t004
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assays, the value of AD50 for the IR homomer was significantly
lower (p#0.05) than that for the b2AR homomer (Table 3). For
the receptor complex consisting of b2AR-RLuc8:IR-GFP
2, the
AD50 value was significantly lower (p#0.05) than the AD50 value
for the IR-RLuc8:b2AR-GFP
2. For heterodimers, there should be
no difference in the relative affinity between AD and DA dimers.
To interpret our data, we developed a simplistic trimer model for
interpretation of AD50 values in a BRET saturation assay.
According to this model, different AD50 values are derived from
theoretical BRET saturation curves with different affinities for
various types of trimer formation (Figure S5). This model should
be used with caution because it does not take into account the
simultaneous formation of dimers, trimers and higher-order
oligomers. Stimulation with the agonists insulin or isoproterenol
did not promote any detectable change in the BRET2 signal (data
not shown), indicating that the receptor dimers/oligomers form
constitutively and that addition of agonists does not induce a
detectable change in the conformational or oligomerization state
of the receptor complexes. However, it needs to be stressed that
BRET only provides information concerning a steady-state
population of dimer/higher-order oligomers and is not suited to
monitor the rapid, ‘‘real-time’’ dynamic type of di2/oligomeri-
zation [55].
To further support the findings from the saturation assays, we
performed homologous and heterologous BRET2 competition
assays where HEK-293 cells were co-transfected with a constant
amount of RLuc8- and GFP2-tagged receptor while increasing the
amount of untagged receptor (Fig. 4A and B). Competition
experiments were carried out at the constant Receptor-GFP2/
Receptor-RLuc8 expression ratio to avoid possible variations in
the BRET2 signal due to fluctuation in the relative expression
levels of the energy donor and acceptor (Fig. 4C and D). It is
expected that the BRET2 signal would decrease if untagged
receptors compete with the tagged receptors for the binding in
complexes. In homologous BRET2 competition assays BRET2
signal decreased with increasing amount of competitor (un-tagged
receptor). In the IR homologous competition assay, we observed a
typical competition curve for dimers, where introduction of the
same amount of untagged receptor produced an approximately
50% reduction in the observed BRET signal. In the b2AR
homologous competition assay, the reduction of the BRET signal
was smaller. This observation cannot be explained by a simple
dimer or trimer model; it could be attributed to clustering of the
b2AR where several acceptors can interact with each donor. In
heterologous competition assays, we observed a transient increase
in the BRET signal with a later hyperbolical decrease (see Fig. 4A
and B). Untagged b2AR caused approximately 1.4-fold increase in
the IR BRET signal, while the effect of untagged IR on the b2AR
BRET signal was less obvious; maximal observed increase was less
than 1.2-fold. The transient increase in the BRET signal with a
subsequent hyperbolical decrease is theoretically predicted for
trimers or higher-order oligomers, where the donor, acceptor and
competitor are all present in the same complex (Figure S6).
Interaction between b2AR and IR characterized by ISM
To support our experimental evidence with the bioinformatics
data, we next applied the informational spectrum method (ISM), a
virtual spectroscopy method to investigate protein-protein inter-
actions and to analyze the structure/function relationship of
proteins. ISM was utilized to identify important informational
characteristic of the interaction between b2AR and IR and identify
the structural determinants potentially involved in receptor
heteromerization. The primary structure of proteins encodes the
information represented by the informational spectrum (IS)
frequencies that correspond to the protein biological function.
Mutually interacting proteins share common information that is
represented by peaks in their cross-spectrum [51]. The informa-
tional spectrum of b2AR is presented in Fig. 5A. It contains two
characteristic peaks at the frequency F(0.216) and F(0.355).
Fig. 5B represents the IS of the IR. By performing cross-spectral
analysis of b2AR and IR, we have identified that these two
molecules share common information corresponding to the IS
frequency F(0.216) (Fig. 5C). To further evaluate the importance
of the peak at F(0.216) we performed CS analysis of b2AR and IR
with scrambled IR and b2AR proteins as negative controls. The
scrambled proteins with the identical amino acid composition to
that of b2AR and IR were created by random permutation of
original proteins. CS analysis between wild type receptors and
randomly selected scrambled b2AR and IR are presented in
Figure S7. The intensity of whole spectrum and the value of
amplitudes at the characteristic peak F(0.216) is higher in CS of
two wild type proteins compared to CS of original and scrambled
proteins confirming the importance of the characteristic peak at
the F(0.216) for interaction between b2AR and IR.
Identification of the key protein domains responsible for
the interaction between b2AR and IR
Computational peptide scanning of b2AR and IR was
performed to identify the regions of proteins essential for
information corresponding to the frequency F(0.216). The
computer-assisted peptide scanning survey of the primary struc-
ture of b2AR with overlapping windows of different lengths
revealed that the region encompassing residues 325–364 is
essential for the information represented by the frequency
F(0.216) (Fig. 6A). Further peptide scanning of IR identified three
principal regions as important for the information represented by
the frequency F(0.216), however region encompassing residues
1269–1314 represents the most probable domain involved in this
interaction (Fig. 6B).
Affinity of interaction between protomers
Peak frequencies in CIS represent common information
encoded by the primary structures of analyzed proteins. Signifi-
cance of information is determined by the signal-to-noise ratio (S/
N), representing the ratio between the signal intensity at one
particular IS frequency and main value of the whole spectrum. A
higher S/N value at the characteristic frequency (F) in CS/CIS of
two or more proteins suggests a higher propensity for their
interaction.
The current analysis showed that the interaction affinities
between the homomers of b2AR and IR are similar and that at the
level of dimer formation, both b2AR and IR displayed a higher
propensity toward homodimerization than heterodimerization
(Table 4). Considering that in the CS of the b2AR and IR, the
two receptors share common information corresponding to the IS
frequency F(0.216), it can be assumed that this frequency is equally
important for heterodimerization and for higher-order hetero-
oligomer formation. The obtained S/N values at F(0.216) in the
CS of b2AR:b2AR:b2AR:IR and b2AR:b2AR:IR:IR tetramers
were comparable, whereas that for the IR trimer displayed a
considerably lower affinity for interaction with the b2AR
monomer (Fig. 7 and Table 4).
Discussion
7TMRs form the largest and most important pharmacothera-
peutic target in drug discovery. Continual discovery of receptor
heteromers expands the repertoire of functional 7TMR units and
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offers promising new targets for drug development (reviewed in
[56]). Increasing evidence for the existence of functional
7TMR:RTK heteromers [7,36,37,38,39] adds another level of
complexity to this system. In the present study, we combined
in vitro experimental and bioinformatics approaches for the
investigation of the interaction between b2AR and IR. Initially,
it was observed that IR coexpression reduces b2AR surface
expression and accelerates its internalization. It could be assumed
that IR increased constitutive internalization of the b2AR [57],
thereby reducing its surface expression. The extent of isoproter-
enol-induced b2AR internalization was comparable to the
previously reported internalization rate for b2AR [58,59]. The
estimated t1/2 of ,9 min for isoproterenol-induced b2AR
internalization is also within the range reported for the same
receptor using a fluorimetric assay [60]. Augmented agonist-
induced b2AR internalization promoted by IR coexpression is in
good agreement with that described in a previous report [61]. The
amount of surface-expressed b2AR lost to internalization in
response to insulin in HEK-293, ,15%, correlated well with
results obtained in DT1MF-2 smooth muscle cells and CHO cells
[61,62] but was smaller than the reported value of ,30% in
epidermoid carcinoma A431 cells [6]. Our colocalization results in
untreated cells correlate well with recent coimmunoprecipitation
findings demonstrating that b2AR and IR form complexes in the
mouse heart, in which the stimulation of IR resulted in the
reduction of the association of the b2AR:IR complex [7].
BRET results provided further evidence for the direct interac-
tion between b2AR and IR. Hyperbolic saturation assay curves are
indicative of a specific constitutive interaction between IR and
b2AR. The BRETmax obtained for b2AR homomerization is
higher than that described in previous reports [19,23,24], whereas
the relative affinity of b2AR for homomerization is within the
previously reported range (AD50 of 1.760.5 vs. 1.2 6 0.33 [23]).
The RLuc8/GFP2 BRET2 donor/acceptor pair used in our study
has the largest Fo¨rster distance R0, leading to 50% of energy
transfer from the donor to acceptor, thereby extending the
maximum distance that the BRET2 system can accurately
measure [63]. Lower reported BRETmax values were obtained
with original BRET1 [19] or BRET2 [23,24] combinations. The
BRETmax values generated in the homologous IR saturation assay
were also slightly higher than that previously reported [29]. The
same study revealed that the substantial insulin-induced effect on
the BRET signal could only be detected with partially purified
fusion IRs [29]. Single-molecule analysis of fluorescently labeled
7TMRs recently demonstrated that b2AR had a high tendency of
forming dimers, even at low densities comparable to receptor
expression in native tissue; however, at higher densities, b2AR
formed a mixture of di-, tri-, and tetramers [55]. Membrane-
driven spatial organization of b2AR also favors its stable/extensive
oligomerization [64]. The inability of agonists to modify the
oligomerization status of b2AR was also reported in studies that
utilized methods other than BRET (reviewed by Ferre et al. [56]).
Both receptors displayed a similar propensity to form homomers as
assessed by AD50 and S/N values. Affinities for the formation of
b2AR:IR and IR:b2AR heteromers differed substantially, a finding
that could not be explained by a dimer model that assumed a
heteromer stoichiometry of 1:1. The lower AD50 value observed
for the b2AR-RLuc8:IR-GFP
2 pair could suggest either a higher
affinity for heteromer formation or, alternatively, complex
oligomer formation. The melatonin MT2 receptor also displayed
a higher propensity for heteromerization with the MT1 receptor
[65], whereas certain receptor pairs (i.e., b1AR:b2AR [23,24],
b2AR:b3AR [20]), oxytocin and vasopressin receptors [66] showed
a similar propensity, and muscarinic acetylcholine receptors [67]
showed a slightly lower propensity for heteromerization. However,
simplistic model for interpretation of AD50 values and heterolo-
gous competition assays data provided evidence for higher-order
oligomeric complex formation. A transient increase in the BRET
signal suggests that the energy transfer efficiency E is increased in
hetero-oligomeric complexes due to the smaller distance between
the BRET donor/acceptor pair in the complex (see Figure S6). A
similar effect–i.e., an increased homo-dimer BRET signal induced
by an unrelated, untagged receptor–was previously observed with
the gastric inhibitory polypeptide receptor [24]. Therefore, both
the change in affinities and transient increase in the BRET signal
could be a reflection of higher-order oligomeric complexes with
affinities for distinct associations such as with trimers and
tetramers with 2:1 and 2:2 stoichiometry, respectively, as proposed
by Breitwieser et al. [68]. At the level of dimer formation, both
b2AR and IR displayed a higher propensity toward homodimer-
ization than heterodimerization, suggesting homodimers as the
basic units engaged in heteromerization. Affinity calculation for
trimers and tetramers highlighted differences between b2AR and
IR. Apparently, neither IR dimers nor trimers could form high
affinity interactions with the b2AR monomer. However, IR
monomers/homodimers can form high affinity heteromers with
b2AR di2/trimers. Considering that both receptors displayed a
higher propensity toward homodimerization and that IR is present
in the plasma membrane as a disulfide-linked dimer [28], it is
plausible to suggest that high-order 7TMR:RTK oligomers most
likely comprise heteromers of homodimers (2:2 stoichiometry).
The computer-assisted peptide scanning survey of the primary
structure of b2AR and IR revealed the domain encompassing
residues 325–364 and 1269–1314 as prospective interaction
domains. The identified region is located at the end of the 7th
TM domain and C-terminal tail of b2AR and almost completely
overlaps with helix 8 (helix adjacent to TM7 running along the
internal membrane surface) of b2AR (residues L324–N357) [69]. A
recent study also identified b2AR helix 8 as an important
dimerization surface region [70]. In addition, this region contains
major sites (Tyr350/Tyr354 and Tyr364) for IR-mediated
phosphorylation of b2AR [3,71] and consensus sites of Akt-
catalyzed phosphorylation (Ser345/Ser 346) [72]. These results
are in accordance with previous findings showing that b2AR is a
substrate for IR and proposing direct interaction between these
proteins [3,71]. The C-terminal cytoplasmic tail–more specifically,
the 15-amino acid motif (residues 342–356)–was sufficient to
confer the b1AR-b2AR tail chimera the ability to be regulated by
insulin [62].
The prospective interaction domain identified in IR (residues
1269–1314) is positioned in the cytoplasmic part of the IR b chain.
This region encompasses the terminal end of the tyrosine kinase
catalytic domain and is a part of the C-terminal tail. The C-
terminal domain of the IR b subunit has been found to play a key
role in the regulation of tyrosine kinase activity [73,74]. The
construct based on proteolytic cleavage used to solve the crystal
structure of the IR tyrosine kinase domain of the human IR B-
isoform [75] ends at residue 1283, which corresponds to the amino
acid at position 1271 in the human IR isoform A used in our study.
Therefore, it could be hypothesized that the terminal end of the IR
tyrosine kinase domain and a part of the C-terminal tail are
involved in the interaction with b2AR.
The involvement of intracellular domains (C-terminal tail and
ICL3) was found to be fundamental for heterodimerization
between the cannabinoid CB1 receptor, adenosine A2A and
dopamine D2 receptors, thus favoring the idea that electrostatic
interactions between intracellular domains are more predominant
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in receptor heteromers and constitute a general mechanism for
receptor heteromerization [76].
In summary, BRET data and ISM bioinformatics provided
evidence for direct interaction and higher-order b2AR:IR
oligomer formation that we hypothesize comprise heteromers of
homodimers and identified prospective intracellular interaction
domains engaged in heteromerization. In this regard,
7TMR:RTK heteromers could potentially generate a basis for
the design of new therapeutics that can compete with today’s
epidemics, such as type-2 diabetes, obesity and cardiovascular
diseases.
Supporting Information
Figure S1 HA-b2AR internalization as quantified by
ELISA. Cells transiently transfected with HA-b2AR (open bars)
or HA-b2AR together with IR (hatched bars) at a 1:1 cDNA ratio
were incubated at 37uC with either isoproterenol (10 mM), insulin
(0.1 mM) or combination of both ligands for 30 min. The amount
of internalized receptor was then calculated from the decrease in
the level of surface-expressed receptor after ligand treatment
compared with untreated, control cells. Data are expressed as the
means 6 S.E. from three independent experiments performed in
triplicate.
(TIF)
Figure S2 Correlation between total luminescence and
fluorescence and the corresponding number of b2AR
binding sites. HEK-293 cells were transfected with increasing
amounts of HA-b2AR-RLuc8 (A) or b2AR-GFP
2 (B) encoding
constructs. The b2AR receptor density (Bmax) was determined by
radioligand binding assays using [125I]-iodopindolol as a tracer as
described in the Material and methods section. Total lumines-
cence was measured after the addition of the RLuc8 substrate
coelenterazine 400a. Total fluorescence was measured with an
excitation filter at 380 nm and an emission filter at 515 nm. The
linear regression curves were generated using GraphPad Prism
5.0. R2 fit values of 0.9705 and 0.9861 were obtained for HA-
b2AR-RLuc8 (A) and b2AR-GFP
2 (B), respectively.
(TIF)
Figure S3 Relationship between receptor-RLuc8 and
receptor-GFP2 constructs expression. Expression levels of
RLuc8- and GFP2-tagged constructs used in BRET2 saturation
assays were also monitored by luminescence and fluorescence
measurements. Total luminescence was measured after the
addition of the RLuc8 substrate coelenterazine 400a. Total
fluorescence was measured with an excitation filter at 380 nm
and an emission filter at 515 nm. Data are expressed as the
means6S.E. of 3–5 independent saturation experiments.
(TIF)
Figure S4 Random collisions between the RLuc8-tagged
receptors and membrane-inserted GFP2-tagged con-
struct (GFP2-17aa). HEK-293 cells were transiently cotrans-
fected with a constant amount of RLuc8-tagged receptors and
increasing amounts of GFP2-17aa encoding construct. BRET2
values were plotted as a function of the ratio between the total
fluorescence/total luminescence (GFP2/RLuc8 ratio). Total lumi-
nescence was measured after the addition of the RLuc8 substrate
coelenterazine 400a. Total fluorescence was measured with an
excitation filter at 380 nm and an emission filter at 515 nm.
Increasing the concentration of GFP2-17aa in cells expressing
either the IR-RLuc8 or b2AR-RLuc8 resulted in high, but
nonspecific linear increase of the BRET2 signal. Data are
expressed as the means 6 S.E. from three independent
experiments performed in triplicate. Representative BRET2
saturation curves of b2AR and IR homomers are shown for
comparison.
(TIF)
Figure S5 Comparison of theoretical BRET saturation
curves with different affinities for trimer formation.
Shown are simulated BRET saturation curves for case with the
same affinity for AAD and ADD formation (solid line) and two
special cases with different affinities for formation of AAD
compared to ADD (hatched and dotted lines). Note that in all
three cases the AD50 values are different. A: acceptor; D: donor.
(TIF)
Figure S6 Numerical simulation of heterologous BRET
competition assay for trimers. Comparison of simulated
BRET competition curves for trimers with the same (E1 =E2= 0.1)
and different (E1 = 0.1, E2 = 0.3) energy transfer ratios for ADD
and ADW, where A, D and W are concentrations of acceptor
(A= 1), donor (D=1) and (W) wild type receptors i.e. competitor.
Transient increase in BRET signal is observed in the case of
different (E1 = 0.1, E2 = 0.3) energy transfer ratios (dotted line).
BRET0 is the BRET signal obtained in the absence of competitor.
(TIF)
Figure S7 Cross-spectrum (CS) of (A) wild type b2AR
and IR, (B) scrambled b2AR and wild type IR and (C)
scrambled IR and wild type b2AR. Note that the value of
amplitudes at the characteristic peak F(0.216) is higher in CS of
two wild type proteins (panel A) compared to the CS of wild type
and scrambled proteins (panels B and C).
(TIF)
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